RE:Some new math for those that play around w mathDJ, If you are refering to the MDA issued on 29th November. Page 6 has some answers to your questions. Total evaluable patients are 43 at 90 Days. And 29 out of the 43 have reached 450 Days. 28% of this 29 evaluable patients are CR. Intermediate responders are still work im progress. Total CR + IR is at 38% at 450 days. That is very impressive.
What I really find stunning is 99.9% Kill rate on 5 different major virus, that is stated on page 9 of the MDA of 29th Nov. This is like fool proof guaranteed to work. This is a huge threat to Pfizer, Moderna and J&J. In addition the dosage required to kill the five viruses is considered relatively safe. I am more excited about the 99.9% kill rate. All the more reason NRC to be involved im the Animal testing. Glad to know the compnay has already designed and produced workimg modeld of TLC 3000B . And PHAC & NRC Will have this 1Q2023 for their testing.